Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Boston Scientific (BSX – Research Report) and CureVac (CVAC – Research Report).
Boston Scientific (BSX)
In a report released today, Pito Chickering from Deutsche Bank maintained a Hold rating on Boston Scientific, with a price target of $73.00. The company’s shares closed last Wednesday at $72.91.
According to TipRanks.com, Chickering is a 4-star analyst with an average return of
Currently, the analyst consensus on Boston Scientific is a Strong Buy with an average price target of $75.44.
See today’s best-performing stocks on TipRanks >>
CureVac (CVAC)
JMP Securities analyst Roy Buchanan reiterated a Buy rating on CureVac today and set a price target of $18.00. The company’s shares closed last Wednesday at $2.51, close to its 52-week low of $2.36.
According to TipRanks.com, Buchanan ‘s ranking currently consits of 0 on a 0-5 ranking scale, with an average return of
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for CureVac with a $18.00 average price target, a 625.8% upside from current levels. In a report issued on April 16, Leerink Partners also maintained a Buy rating on the stock.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on BSX:
